Additionally, the technology provides women with an easy, effective and completely non-invasive treatment option, empowering them to address an often private health issue that can dramatically impact their quality of life.

Incontinence is actually caused by a weakening of the muscles within the pelvic floor region, often a result of childbirth, menopause and the natural aging process. Although incontinence is extremely common, 5 out of 10 women do not seek help, according to the National Association for Continence (NAFC), which can have a dramatic effect on a woman’s self-esteem and confidence. “Given how common this is for women, it always surprises me that women keep it to themselves as many of their friends and colleagues are suffering as well,” shared Sculpted Wellness. “By the time they come to me, they’re really at loss and are excited to learn about BTL EMSELLA®, the completely non-invasive nature of the treatment allows it to be approachable, making it easy for women to treat this issue and stop suffering in silence.” Harnessing the power of HIFEM (High-Intensity Focused Electromagnetic) technology, BTL EMSELLA® stimulates the entire pelvic floor at once—with a single session providing thousands of supramaximal pelvic floor muscle contractions, comparable to thousands of Kegels. Supramaximal pelvic floor muscle contractions are extremely important in muscle re-education of incontinent patients.

A recent clinical study demonstrated that 100% of patients had better awareness of pelvic floor muscles as a result of treatment, with 95% of patients treated reported satisfaction and significant improvement in their quality of life following six treatments with BTL EMSELLA®.

For optimal results with BTL EMSELLA® Sculpted Wellness recommends a series of six, twice–weekly, 28-minute treatments.

US FDA Clearance:
Emsella® is intended to provide entirely non-invasive electromagnetic stimulation of pelvic floor musculature for the purpose of rehabilitation of weak pelvic muscles and restoration of neuromuscular control for the treatment of male and female urinary incontinence.